MDROS are defined as microorganisms, predominantly bacteria, that are resistant to one or more classes of antimicrobial agents.
Bacteria that resist treatment with more than one antibiotic are called multidrug-resistant organisms (MDROs for short). Multidrug-resistant organisms are found mainly in hospitals and long-term care facilities. Multidrug-resistant organism infections are hard to treat because they do not respond to many common antibiotics, even the most powerful ones. But certain antibiotics can still help control MDROs in most people. The doctor will try to find the type of MDRO causing the illness. Like MRSA, Vancomycin-intermediate Staphylococcus aureus (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA) are types of staph bacteria that are resistant (or have intermediate resistance) to certain antibiotics. Because of their resistance to antibiotics, VISA/VRSA infections can be more difficult to treat. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of Staphylococcus (staph) bacteria that is resistant to certain antibiotics called beta-lactams. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin, and amoxicillin Multidrug-resistant organisms (MDROs) are bacteria that are not able be treated with certain types of antibiotics and require treatment with other medicines that may be less effective, more toxic, and more expensive. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of Staphylococcus (staph) bacteria that is resistant to certain antibiotics called beta-lactams. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin, and amoxicillin Strains of S. aureus that have intermediate susceptibility or are resistant to vancomycin (i.e., vancomycin-intermediate S. aureus [VISA], vancomycin-resistant S. aureus [VRSA]) (20-30) have affected specific populations, such as hemodialysis patients. Similarly, therapeutic options are limited for ESBL-producing isolates of gram-negative bacilli, strains of A. baumannii resistant to all antimicrobial agents except imipenem(8-11, 38) and intrinsically resistant Stenotrophomonas sp.(12-14, 39). Infection means that bacteria are in or on your body and causing an illness or other medical condition. Infection with a MDRO occurs most often in young children, the elderly, or in people who have an existing severe illness or a health condition such as chronic lung, heart, or kidney disease. Multidrug-resistant organism infections are hard to treat because they do not respond to many common antibiotics, even the most powerful ones. But certain antibiotics can still help control MDROs in most people. The doctor will try to find the type of MDRO causing the illness. Definition. Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type of staph bacteria that's become resistant to many of the antibiotics used to treat ordinary staph infections. When it occurs in these settings, it's known as health care-associated MRSA (HA-MRSA). HA-MRSA infections typically are associated with invasive procedures or devices, such as surgeries, intravenous tubing or artificial joints. Another type of MRSA infection has occurred in the wider community — among healthy people. Clinical importance of MDROs. In most instances, MDRO infections have clinical manifestations that are similar to infections caused by susceptible pathogens. However, options for treating patients with these infections are often extremely limited. Similarly, therapeutic options are limited for ESBL-producing isolates of gram-negative bacilli, strains of A. baumannii resistant to all antimicrobial agents except imipenem(8-11, 38) and intrinsically resistant Stenotrophomonas sp.(12-14, 39). MDRO definition. For epidemiologic purposes, MDROs are defined as microorganisms, predominantly bacteria, that are resistant to one or more classes of antimicrobial agents (1). Similarly, therapeutic options are limited for ESBL-producing isolates of gram-negative bacilli, strains of A. baumannii resistant to all antimicrobial agents except imipenem(8-11, 38) and intrinsically resistant Stenotrophomonas sp.(12-14, 39). are going to be around for the foreseeable future for sure, but that doesn't mean we can't be judicious and control how we use antibiotics and how we can prevent the emergence of these resistant organisms with good infection prevention practices and the use of antimicrobial agents, Condoluci advises. 
http://www.ct.gov/dph/cwp/view.asp?a=3136&q=424162 http://www.vdh.virginia.gov/epidemiology/surveillance/hai/MRSAandMDRO.htm http://www.vdh.virginia.gov/epidemiology/surveillance/hai/MRSAandMDRO.htm http://www.cdc.gov/hicpac/mdro/mdro_2.html http://www.ct.gov/dph/cwp/view.asp?a=3136&q=424162 http://www.mayoclinic.org/diseases-conditions/mrsa/basics/definition/CON-20024479 http://www.cdc.gov/hicpac/mdro/mdro_2.html http://www.cdc.gov/hicpac/mdro/mdro_2.html http://acronyms.thefreedictionary.com/MDRO
mdros definition